begin privacyenhanced message proctype 2001micclear originatorname webmasterwwwsecgov originatorkeyasymmetric mfgwcgyevqgbaqicaf8dsgawrwjaw2snkk9avtbzyzmr6agjlwyk3xmzv3dtinen twsm7vrzladbmyqaionwg5sdw3p6oam5d3tdezxmm7z1tbtwidaqab micinfo rsamd5rsa fsocbzfqfykf7x16bgba2sc7qlb0xpszofbulbhvzspq8mnsmmixnc0cjbwaa rbby4v2kabux2bajngr8w 000119312509145925txt 20090708 000119312509145925hdrsgml 20090708 20090708172955 accession number 000119312509145925 conformed submission type sc 14d9a public document count 2 filed date 20090708 date change 20090708 subject company company data company conformed name endocare inc central index key 0001003464 standard industrial classification electromedical electrotherapeutic apparatus 3845 irs number 330618093 state incorporation de fiscal year end 1231 filing value form type sc 14d9a sec act 1934 act sec file number 00550293 film number 09935686 business address street 1 201 technology drive city irvine state ca zip 92618 business phone 8004184677 mail address street 1 201 technology drive city irvine state ca zip 92618 filed by company data company conformed name endocare inc central index key 0001003464 standard industrial classification electromedical electrotherapeutic apparatus 3845 irs number 330618093 state incorporation de fiscal year end 1231 filing value form type sc 14d9a business address street 1 201 technology drive city irvine state ca zip 92618 business phone 8004184677 mail address street 1 201 technology drive city irvine state ca zip 92618 sc 14d9a 1 dsc14d9ahtm amendment no 1 schedule 14d9 amendment no 1 schedule 14d9 security exchange commission washington dc 20549 schedule 14d9 rule 14d101 solicitationrecommendation statement pursuant section 14d4 security exchange act 1934 amendment no 1 endocare inc name subject company endocare inc name person filing statement common stock par value 0001 per share title class security 29264p104 29264p203 cusip number class security michael r rodriguez senior vice president finance chief financial officer endocare inc 201 technology drive irvine california 92618 949 4505400 name address telephone number person authorized receive notice communication behalf person filing statement copy to clint b davis senior vice president legal affair general counsel secretary endocare inc 201 technology drive irvine california 92618 949 4505400 michelle a hodges david c lee gibson dunn crutcher llp 3161 michelson drive suite 1200 irvine california 92612 949 4513800 ¨ check box filing relates solely preliminary communication made commencement tender offer amendment no 1 this “amendment” amends supplement solicitationrecommendation statement schedule 14d9 endocare inc delaware corporation “endocare” “company” originally filed security exchange commission the “sec” june 17 2009 a amended supplemented time time “statement” relating offer healthtronics inc georgia corporation “healthtronics” whollyowned subsidiary ht acquisition inc delaware corporation “purchaser” acquire issued outstanding share endocare’s common stock par value 0001 per share exchange i 135 cash without interest the “cash consideration” ii 07764 share healthtronics common stock the “stock consideration” case election holder subject proration upon term subject condition set forth healthtronics’ prospectus a amended supplemented time time “prospectus” contained registration statement form s4 originally filed healthtronics sec june 17 2009 the “registration statement” related letter election transmittal the “letter transmittal” together prospectus amendment supplement thereto “offer” unless otherwise indicated term used herein defined shall meaning ascribed statement item 2 identity background filing person item 2 statement hereby amended supplemented adding following paragraph eleventh paragraph item 2 july 7 2009 galil endocare healthtronics purchaser entered settlement agreement whereby among matter galil agreed dismiss lawsuit galil filed june 9 2009 court chancery state delaware endocare merger sub civil action no 4655cc the “galil litigation” described section item 8 statement entitled “legal proceedings” fully released endocare purchaser healthtronics claim related galil merger agreement merger agreement agreement related thereto transaction contemplated galil merger agreement exchange payment 175 million the “settlement payment” result settlement payment adjustment amount zero dollar cash consideration stock consideration payable offer merger increased item 8 additional information item 8 statement hereby amended supplemented replacing second paragraph section item 8 entitled “legal proceedings” entirety following july 7 2009 galil endocare healthtronics purchaser entered settlement agreement whereby among matter galil agreed dismiss galil litigation fully released endocare purchaser healthtronics claim related galil merger agreement merger agreement agreement related thereto transaction contemplated galil merger agreement exchange payment endocare 175 million payable july 9 2009 forwardlooking statement statement made amendment strictly historical including statement regarding plan objective future financial performance “forwardlooking” statement although endocare belief expectation reflected forwardlooking statement reasonable assurance given expectation prove correct factor could cause actual result differ materially expressed implied forwardlooking statement include among others risk offer merger close risk healthtronics’ business andor endocare’s business adversely impacted pendency offer merger risk operation two company integrated successfully risk healthtronics’ expected cost saving synergy transaction may fully realized realized take longer realize anticipated risk demand acceptance healthtronics’ endocare’s product service may reduced risk change governmental regulation impact economic condition impact competitive technological change risk factor relating industry including detailed time time endocare’s report filed sec assurance proposed merger fact consummated place undue reliance forwardlooking statement speak date amendment unless required law endocare undertakes obligation update forwardlooking statement whether result new information future event otherwise statement made connection offer subject safe harbor protection provided forwardlooking statement private security litigation reform act 1995 item 9 exhibit item 9 statement hereby amended supplemented adding following exhibit exhibitno description a6 press release issued july 7 2009 signature due inquiry best knowledge belief certify information set forth statement true complete correct endocare inc by s michael r rodriguez name michael r rodriguez title senior vice president finance chief financial officer dated july 8 2009 ex99a6 2 dex99a6htm press release press release exhibit a6 endocare galil medical announce settlement litigation irvine ca yokneam israel july 7 2009 endocare inc nasdaq endo privately held galil medical ltd today announced entered settlement agreement stipulating termination previously announced merger agreement endocare galil medical pursuant endocare would acquired galil medical settlement related litigation delaware chancery court endocare endocare inc—wwwendocarecom— innovative medical device company focused development minimally invasive technology tissue tumor ablation endocare initially concentrated developing technology treatment prostate cancer belief proprietary technology broad application across number market including ablation tumor kidney lung liver palliative intervention treatment pain associated metastasis galil medical galil medical global medical device company develops manufacture market innovative product utilizing proprietary cryoablation platform incorporates powerful freezing technology revolutionary 17gauge cryoablation needle design company office yokneam israel plymouth meeting pennsylvania london shareholder include thomas mcnerney partner vertical group investor growth capital elron electronic industry ltd nasdaqelrn rdc rafael development corporation ltd end privacyenhanced message